| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Iovance Biotherapeutics, Inc. (IOVA) has 12 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. IOVA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.0K | $850.7K | - | |
| Dir | 135.1K | $489.0K | - | |
| Other | 132.2K | $478.6K | - | |
| CFO | 132.2K | $478.6K | - | |
| Other | 117.5K | $425.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | 30,000 | $1.84 | $55,200.00 | New | +22.8% | - | |
| May 23, 2025 | Puri Raj K. | Chief Regulatory Officer | Buy | 5,600 | $1.74 | $9,743.44 | +2.8% | +42.7% | - | |
| May 14, 2025 | Vogt Frederick G59 | Interim CEO &General Counsel | Buy | 25,000 | $1.69 | $42,250.00 | +7.2% | +30.8% | - | |
| Nov 12, 2024 | Maynard Ryan D75 | Director | Sale+OE | 50,000 | $10.06 | $503,000.00 | -87.0% | -45.1% | -73.8% | |
| Feb 20, 2024 | Dukes Iain D. | Director | Buy | 32,000 | $9.15 | $292,800.00 | +145.5% | -14.0% | -53.0% | |
| Feb 20, 2024 | McPeak Merrill A55 | Director | Buy | 250,000 | $9.15 | $2,287,500.00 | +356.4% | -14.0% | -53.0% | |
| Feb 20, 2024 | Rothbaum Wayne P.60 | Director | Buy | 5,000,000 | $9.15 | $45,750,000.00 | +21.7% | -14.0% | -53.0% | |
| Sep 18, 2023 | McPeak Merrill A55 | Director | Buy | 10,000 | $5.56 | $55,600.00 | +4.2% | +32.4% | +75.7% | |
| Sep 15, 2023 | Rothbaum Wayne P.60 | Director | Buy | 5,000,000 | $5.30 | $26,500,000.00 | +27.7% | +46.3% | +96.2% | |
| Dec 21, 2022 | McPeak Merrill A55 | Director | Buy | 10,000 | $6.15 | $61,500.00 | +16.6% | +4.0% | +30.4% |